Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. on March 9, 2018, reporting an event that occurred on March 6, 2018. The filing addresses the expansion of Medicare coverage for the company's Argus II Retinal Prosthesis System.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory coverage event rather than financial performance data.
Material Changes
Palmetto GBA (Jurisdiction JJ), a Medicare Administrative Contractor, has approved coverage for the Argus II and the related surgical procedure. This decision extends coverage to Alabama, Georgia, and Tennessee. Consequently, the total coverage area for the Argus II now encompasses 31 states, two territories, and the District of Columbia.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the coverage expansion. The filing does not contain forward-looking guidance, specific risk factors, contingencies, or unusual items beyond the regulatory update.
Investor Verification Checklist
- Verify the specific reimbursement rates and billing codes associated with the new coverage in Alabama, Georgia, and Tennessee.
- Confirm the total number of states and territories covered to date (31 states, 2 territories, DC).
- Review the attached press release (Exhibit 99.1) for details on the commercial impact of the Palmetto GBA decision.
- Note that the registrant name in the filing header is Second Sight Medical Products, Inc., despite the request metadata referencing Vivani Medical, Inc.